Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Greece is the word: BASF tells Pronova shareholders revised bid is fair value

By Gareth MacDonald+

Last updated on 16-Jan-2013 at 17:31 GMT2013-01-16T17:31:03Z

BASF cites Greek non-reimbursement in revised Pronova bid
BASF cites Greek non-reimbursement in revised Pronova bid

BASF says revised offer for omega-3 API maker Pronova Biopharma is fair value given recent Greek Government decision to stop reimbursing two key drugs. 

The German Chemicals giant raised its offer for Norway-based Pronova today , upping its previous bid of €644m to €684m after minority shareholders Odin Forvaltning AS and Nykredit Asset Management said the original proposal was too low.

BASF spokesman Thomas Nonnast acknowledged this resistance as a factor in the revised bid, telling “the increased offer price is a concession to the shareholders of Pronova to enable a transaction.

He also suggested that further revisions to the bid are unlikely before the offer deadline expires on January 18.

Fundamentally, there is no further information that would require an increase in the offer price,” he said, adding that “In fact, the most recent news flow around Pronova was rather negative.”


On January 11, Pronova announced that its Omacor and Zodin products had been placed on the negative reimbursement list in Greece, meaning that the state will no longer pay for either of the two drugs as part of a wider round of public healthcare cost cutting.

Greece is one of Pronova’s key markets with around 4 per cent of the firm’s NOK1.8bn ($323m) revenue coming from the country each year.

Pronova has not said what impact inclusion on the non-reimbursement list is likely to have on revenue; however its decision to appeal the ruling – in collaboration with partners Abbott Laboratories and Grupo Ferrer – suggests it would rather not lose the sales.

The firm did not respond to's request for information ahead of publication.

Fair value says BASF

Nonnast said that – with the Greek decision in mind – BASF's revised “offer is an attractive opportunity for all Pronova shareholders to sell their shares at a full and fair value, particularly taking into consideration the very low trading liquidity of Pronova shares, and that it provides the best solution for Pronova's stakeholders.”

Whether this will be enough to convince resistant shareholders before the offer expires on Friday remains to be seen.

Earlier today Odin Forvaltning AS - which holds a 4.7 per cent stake in Pronova - said that it is still not satisfied with the BASF offer according to Bloomberg .

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars